Business Description
Mereo BioPharma Group is a UK-based medical company focused on developing treatments for rare and serious diseases, operating across both the United Kingdom and the United States. Founded in 2015 and headquartered in London, the company is advancing a range of drug candidates targeting conditions such as brittle bone disease, lung disease, certain cancers, and hormonal disorders. Several of these treatments are currently in clinical trials, with others being developed through partnerships with companies including AstraZeneca, Feng Biosciences, and ReproNovo.
